Clinical Trial Update: Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nasal carbon dioxide for temporomandibular disorder-related pain has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Temporomandibular Disorders

Drugs mentioned

• Nasal CO2 (carbon dioxide)

Snippet

Sponsor: Capnia, Inc. | Conditions: Temporomandibular Disorders, Pain | Phase 2 | Status: COMPLETED